ReviewInternational journal of women's health2014
Menstrual suppression: current perspectives.
Review in International journal of women's health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Contraception and Amenorrhea: An Exploratory Cross-Sectional Study on Acceptability in Filipino/Filipino-American Women.Journal of transcultural nursing : official journal of the Transcultural Nursing Society · 2026Article
- Contraceptive-induced menstrual changes in low- and middle-income countries: a systematic scoping review.Communications medicine · 2025Article
- Article
- REPRODUCTIVE HEALTH IN TRANS AND GENDER DIVERSE PATIENTS: Contraception considerations in transmasculine and gender diverse adolescents and young adults.Reproduction (Cambridge, England) · 2025Review
- Effect of Menstrual Cycle and Hormonal Contraception on Musculoskeletal Health and Performance: Protocol for a Prospective Cohort Design and Cross-Sectional Comparison.JMIR research protocols · 2024Article
- Angiogenesis in abnormal uterine bleeding: a narrative review.Human reproduction update · 2023Review
- Determinants of anaemia among women of reproductive age in South Africa: A Healthy Life Trajectories Initiative (HeLTI).PloS one · 2023Article
- Clinical Diagnosis and Early Medical Management for Endometriosis: Consensus from Asian Expert Group.Healthcare (Basel, Switzerland) · 2022Review
- An Epidemiologic Review of Menstrual Blood Loss as an Excretion Route for Per- and Polyfluoroalkyl Substances.Current environmental health reports · 2022Review
- Multilevel analysis of determinants of anemia among young women (15-24) in sub-Sahara Africa.PloS one · 2022Article
- Blood management strategies in congenital Glanzmann thrombasthenia at a hematology referral center.Blood research · 2021Article
- The Impact of Progestin-only Contraception on Adolescents with Macromastia.Plastic and reconstructive surgery. Global open · 2021Article
- Identifying risk factors of anemia among women of reproductive age in Rwanda - a cross-sectional study using secondary data from the Rwanda demographic and health survey 2014/2015.BMC public health · 2019Article
- The myth of menstruation: how menstrual regulation and suppression impact contraceptive choice.BMC women's health · 2019Article
- Health-related quality of life in undergraduate women using any contraceptive.Health and quality of life outcomes · 2019Article
- Prolonged Amenorrhea and Resumption of Menses in Women with HIV.Journal of women's health (2002) · 2018Article
- Medically induced amenorrhea in female astronauts.NPJ microgravity · 2016Review
- Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Menstrual suppression to provide relief of menstrual-related symptoms or to manage medical conditions associated with menstrual morbidity or menstrual exacerbation has been used clinically since the development of steroid hormonal therapies. Options range from the extended or continuous use of combined hormonal oral contraceptives, to the use of combined hormonal patches and rings, progestins given in a variety of formulations from intramuscular injection to oral therapies to intrauterine devices, and other agents such as gonadotropin-releasing hormone (GnRH) antagonists. The agents used for menstrual suppression have variable rates of success in inducing amenorrhea, but typically have increasing rates of amenorrhea over time. Therapy may be limited by side effects, most commonly irregular, unscheduled bleeding. These therapies can benefit women's quality of life, and by stabilizing the hormonal milieu, potentially improve the course of underlying medical conditions such as diabetes or a seizure disorder. This review addresses situations in which menstrual suppression may be of benefit, and lists options which have been successful in inducing medical amenorrhea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.